Prostate cancer breakthrough as new drug combo gives high-risk patients a powerful new chance
Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease progression or death
Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease progression or death
Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease progression or death
The full story continues on Independent.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.